JP Morgan Chase’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34K Buy
+483
New +$29.5K ﹤0.01% 6715
2025
Q2
– Hold
0
– – – 7018
2025
Q1
– Hold
0
– – – 7264
2024
Q4
– Hold
0
– – – 7359
2024
Q3
– Hold
0
– – – 7352
2024
Q2
– Sell
-63
Closed -$3 – 7522
2024
Q1
$3 Buy
+63
New +$2.87K ﹤0.01% 7293
2023
Q4
– Sell
-111
Closed -$4.52K – 7656
2023
Q3
$4.5K Buy
+111
New +$5.05K ﹤0.01% 6390
2023
Q2
– Hold
0
– – – 6854
2023
Q1
– Hold
0
– – – 6638

Other funds holding GNOM

JP Morgan Chase's GNOM Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q3 2026: 483 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #6715 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in GNOM as recently as Q1 2024.

JP Morgan Chase first reported a position in GNOM in Q3 2023 and has held it in 3 quarters since. 51 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.

  • JP Morgan Chase held 483 shares of Global X Genomics & Biotechnology ETF worth $34K as of Q3 2026.
  • Global X Genomics & Biotechnology ETF was a new JP Morgan Chase position in Q3 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #6715 holding.
  • JP Morgan Chase first reported a position in Global X Genomics & Biotechnology ETF in Q3 2023 and has held it in 3 quarters since.
  • 51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.